EA-B2L
EA-B2L is a GSTP degrader with a DC50 of 48 μM in HeLa cells. EA-B2L inhibits GSTP enzymatic activity, induces dose-dependent GSTP degradation via the ubiquitin-proteasome and autophagy pathways, and does not activate the 20S proteasome subunit. EA-B2L induces dose-dependent apoptosis in cancer cells, a process associated with GSTP degradation, caspase 3 activation, and PARP cleavage. EA-B2L exerts dose-dependent antiproliferative effects on cancer cells with high GSTP expression. EA-B2L can be used in the research of cervical cancer, lung cancer, and fibrosarcoma.
For research use only. We do not sell to patients.
- CAS No.: 1354444-72-6
- Formula: C35H54Cl2N4O8
- Molecular Weight:729.73
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
GSTP 48 nM (DC50) |
Caspase 3 |
PARP |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
16.87 μM
|
Antiproliferative activity against human cervical carcinoma HeLa cells assessed as reduction in cell viability by CCK-8 assay.
Antiproliferative activity against human cervical carcinoma HeLa cells assessed as reduction in cell viability by CCK-8 assay.
|
39563816 |
| A549 | IC50 |
32.06 μM
|
Antiproliferative activity against human lung carcinoma A549 cells assessed as reduction in cell viability by CCK-8 assay.
Antiproliferative activity against human lung carcinoma A549 cells assessed as reduction in cell viability by CCK-8 assay.
|
39563816 |
| HT-1080 | IC50 |
19.32 μM
|
Antiproliferative activity against human fibrosarcoma HT1080 cells assessed as reduction in cell viability by CCK-8 assay.
Antiproliferative activity against human fibrosarcoma HT1080 cells assessed as reduction in cell viability by CCK-8 assay.
|
39563816 |
In Vitro
EA-B2L (80 μM; 0.5 h) potently inhibits purified recombinant human GSTP enzyme activity with 92.26% inhibition at 80 μM[1].
EA-B2L (10-80 μM; 24 h) induces dose-dependent GSTP degradation in HeLa cells with a DC50 of 48 μM and 85.3% maximum degradation at 80 μM after 24-hour incubation[1].
EA-B2L (5-80 μM; 3 h) induces dose-dependent GSTP degradation in Cycloheximide (HY-12320)-pretreated HeLa cells, with more obvious degradation at concentrations greater than 40 μM after 3-hour incubation[1].
EA-B2L (80 μM; 0.5 h preincubation, 1 h substrate incubation) does not significantly alter the catalytic activity of purified human 20S proteasome β1, β2, or β5 subunits at 80 μM[1].
EA-B2L (80 μM; 24 h after 30 min inhibitor pretreatment)-induced GSTP degradation in HeLa cells is mediated by both the autophagy-lysosome and ubiquitin-proteasome pathways, requiring ubiquitylation of GSTP[1].
EA-B2L potently inhibits the proliferation of HeLa, A549, and HT1080 cancer cells with IC50 values of 16.87 μM, 32.06 μM, and 19.32 μM, respectively[1].
EA-B2L (20-80 μM; 24 h) induces dose-dependent apoptotic cell death in HeLa cells, with ~92% apoptotic population at 40 μM after 24-hour incubation, accompanied by caspase 3 activation and PARP cleavage[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human cervical carcinoma HeLa cells
-
Concentration:10 μM; 20 μM; 40 μM; 80 μM
-
Incubation Time:24 h
-
Result:Induced significant GSTP degradation at 80 μM, with minimal degradation observed at concentrations below 40 μM.
Exhibited a DC50 of 48 μM.
Achieved 85.3% maximum GSTP degradation (Dmax) at 80 μM.
-
Cell Line:Cycloheximide-pretreated human cervical carcinoma HeLa cells
-
Concentration:5 μM; 10 μM; 20 μM; 40 μM; 80 μM
-
Incubation Time:3 h
-
Result:Induced dose-dependent GSTP degradation, with more pronounced degradation observed at concentrations above 40 μM.
-
Cell Line:human cervical carcinoma HeLa cells
-
Concentration:80 μM
-
Incubation Time:24 h (after 30 min inhibitor pretreatment)
-
Result:Induced GSTP degradation that was blocked by pretreatment with Bafilomycin A1, MG132, PYR-41, or b-AP15.
-
Cell Line:human cervical carcinoma HeLa cells
-
Concentration:20 μM; 40 μM; 60 μM; 80 μM
-
Incubation Time:24 h
-
Result:Induced dose-dependent apoptosis: generated ~92% apoptotic population at 40 μM.
Triggered caspase 3 activation and PARP cleavage in treated cells.
Chemical Information
-
CAS No. 1354444-72-6
-
Molecular Weight 729.73
-
Formula C35H54Cl2N4O8
-
SMILES
CCC(C(C1=C(C(Cl)=C(C=C1)OCC(NCCCCCCNC([C@H](CCCCNC(OC(C)(C)C)=O)NC(OC(C)(C)C)=O)=O)=O)Cl)=O)=C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)